spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Watson Pharmaceuticals 

 HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2019
Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 8 Aug 2018
Allergan Appoints Neurobiology Expert Michael E. Greenberg, PhD to its Board of Directors as Part of Active Board Refreshment Process
Biopharmaceuticals Ophthalmology Dermatology Personnel
 HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 31 Jul 2017
Amgen and Allergan Submit Biosimilar Biologics License Application for ABP 980 to US Food and Drug Administration
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 29 Mar 2016
Shire Wins Patent Trial Against Watson Concerning LIALDA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Jul 2015
Ophthotech Announces New Senior Leadership Appointments
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 11 Mar 2014
Sorrento Therapeutics Appoints Mark Durand to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Dec 2013
Vensun Pharmaceuticals, Inc. Completes Series B Financing
Biopharmaceuticals Generics Venture Capital
 HSMN NewsFeed - 13 Nov 2013
Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Feb 2013
Actavis' Generic Suboxone(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Nov 2012
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2012
Watson Announces Lidoderm(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jan 2012
Watson Acquires Ascent Pharmahealth for AU$375 Million
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 May 2011
Watson Acquires Specifar Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2011
Columbia Laboratories Appoints Kip Martin as Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2011
Shire Files Lawsuit Against Watson Pharmaceuticals, Inc. for Infringement of ADDERALL XR(R) Patents and for Breach of Contract
Biopharmaceuticals Litigation
 HSMN NewsFeed - 25 Mar 2011
Watson Confirms District Court Ruling in Generic Fentora(R) Patent Suit
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Mar 2011
Cephalon Wins FENTORA Patent Suit Against Watson
Biopharmaceuticals Pain Management Generics Litigation
 HSMN NewsFeed - 25 Jan 2011
Catalyst Pharmaceutical Partners Promotes Steven R. Miller, Ph.D. to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2010
Watson and Richter Announce Exclusive License Agreement for Esmya
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Dec 2010
PROCHIEVE 8% Vaginal Progesterone Gel Achieves Primary Endpoint in Phase III Study to Reduce Risk of Preterm Birth
Biopharmaceuticals
 HSMN NewsFeed - 3 Dec 2010
Shire Files Suit Against Impax and Watson
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Nov 2010
Arbor Pharmaceuticals Completes $34.8 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Nov 2010
Aqua Pharmaceuticals Welcomes Skip Williams as Executive Director of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2010
Watson's Generic Version of Lotrel(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Sep 2010
Itero Biopharmaceuticals Appoints Debanjan Ray to Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Watson's Generic Yasmin(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Sep 2010
Watson Confirms Combigan(R) Patent Challenge
Biopharmaceuticals Generics Ophthalmology Litigation
 HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2010
FDA Grants Approval of ella(R) for Emergency Contraception
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jun 2010
MonoSol Rx Appoints Dr. Mary Ellen Norvitch Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 5 May 2010
Frank C. Condella, Jr. Appointed President and Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology
 HSMN NewsFeed - 10 Mar 2010
Watson Announces Actos(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Mar 2010
Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Feb 2010
Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and Symptoms of BPH (Benign Prostatic Hyperplasia)
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 1 Feb 2010
Watson and HRA Pharma Announce Exclusive Licensing Agreement to Commercialize Novel Emergency Contraceptive in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2010
Watson Files FDA Application for Generic LoSeasonique(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology
 HSMN NewsFeed - 2 Dec 2009
Watson Completes Acquisition of Arrow Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Nov 2009
Watson Names Robert A. Stewart Senior Vice President, Global Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2009
Watson Names R. Todd Joyce Senior Vice President and Chief Financial Officer; Succeeds Mark W. Durand
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2009
Watson and Barr Settle Lawsuit Over Oxytrol(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Aug 2009
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jul 2009
Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 27 Jul 2009
Watson CFO Mark W. Durand to Take Leave of Absence
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2009
Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
Biopharmaceuticals Urology Oncology FDA
 HSMN NewsFeed - 29 Jun 2009
Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2009
Thomas P. Rice Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Depomed Names Shay Weisbrich Vice President of Marketing
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology
 HSMN NewsFeed - 13 May 2009
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 8 May 2009
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Biopharmaceuticals Urology
 HSMN NewsFeed - 22 Apr 2009
Watson Files FDA Applications for Generic Mucinex(R)
Biopharmaceuticals Generics Litigation FDA
 HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Mar 2009
Watson Announces a Nationwide Voluntary Recall of Propafenone HCL Tablets Due to Oversized Tablets
Biopharmaceuticals Generics Product Recall
 HSMN NewsFeed - 6 Mar 2009
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 5 Jan 2009
Depomed Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2008
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 16 Dec 2008
Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 25 Nov 2008
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Biopharmaceuticals Acquisitions Generics
 HSMN NewsFeed - 8 Oct 2008
Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals FDA Urology
 HSMN NewsFeed - 23 Jul 2008
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 3 Jun 2008
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 3 Jun 2008
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jun 2008
Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 May 2008
MonoSol Rx Appoints John McCracken Senior Vice President Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 12 May 2008
Watson Pharmaceuticals Announces Appointment of Andrew L. Turner as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2008
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
Biopharmaceuticals Devices Drug Delivery Oncology FDA
 HSMN NewsFeed - 21 Apr 2008
Watson Files FDA Application for Generic YASMIN(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 28 Mar 2008
Barr Announces Reorganization of Senior Management, Business Functions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
Biopharmaceuticals
 HSMN NewsFeed - 5 Mar 2008
Barr Subsidiary Sues Watson for SEASONIQUE(R) Patent Infringement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 20 Feb 2008
Depomed Names Abid Rawn Vice President of Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2008
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Jan 2008
Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 3 Jan 2008
Watson Launches Generic Biaxin(R) XL
Biopharmaceuticals Generics
 HSMN NewsFeed - 2 Jan 2008
Depomed Receives FDA Approval for 1000 mg Strength Tablets of Glumetza
Biopharmaceuticals FDA Endocrinology Drug Delivery
 HSMN NewsFeed - 14 Dec 2007
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Dec 2007
Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Dec 2007
Watson and Biovail Settle Lawsuit Over Cardizem(R) LA
Biopharmaceuticals Litigation
 HSMN NewsFeed - 4 Dec 2007
Biovail Announces Settlement Agreement Related to Cardizem(R) LA
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Dec 2007
Depomed Names Michael Sweeney Vice President of Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Nov 2007
Watson Receives FDA Approval For Generic Combunox(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Nov 2007
Watson Files FDA Application for Generic YAZ(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Nov 2007
NexMed Appoints Hem Pandya as Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Oct 2007
Depomed and King Pharmaceuticals Terminate Promotion Agreement for GLUMETZA(TM)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 29 Oct 2007
Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
Biopharmaceuticals Generics
 HSMN NewsFeed - 11 Oct 2007
Depomed Announces Retirement of Chief Financial Officer John F. Hamilton
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2007
Watson Files Application for Generic FEMCON(R) Fe
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 26 Sep 2007
Watson Receives FDA Approval for Generic Accuneb(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Sep 2007
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2007
Depomed Announces Reduction in Force
Biopharmaceuticals
 HSMN NewsFeed - 27 Aug 2007
Dr. John Fara Retires as Chairman, President and CEO of Depomed; Mr. Carl Pelzel Appointed President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2007
Watson Receives FDA Approval For Generic Duragesic(R)
Biopharmaceuticals FDA Generics Drug Delivery
 HSMN NewsFeed - 20 Aug 2007
Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Aug 2007
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2007
Watson Announces CEO Succession Plan
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2007
Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol Succinate Extended-Release 50 mg Tablets; Relinquishes 180-Day Market Exclusivity
Biopharmaceuticals Generics
 HSMN NewsFeed - 8 Mar 2007
Melvin Sharoky Elected to Board of Directors of Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2007
Biovail Announces Comprehensive Settlement Related to Wellbutrin XL(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Feb 2007
Watson and GlaxoSmithKline Settle Lawsuit Over Wellbutrin Xl(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 Jan 2007
Home Diagnostics Appoints Vice President of Marketing
Diagnostics Personnel
 HSMN NewsFeed - 16 Jan 2007
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 12 Jan 2007
Napo Pharmaceuticals, Inc. Appoints Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2007
Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Dec 2006
Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
Biopharmaceuticals Generics
 HSMN NewsFeed - 14 Dec 2006
Stellar Pharmaceuticals Signs License and Supply Agreements With Watson Pharmaceuticals for Stellar's Uracyst'R' Product
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 11 Dec 2006
Watson Appoints Thomas Giordano as Senior Vice President, Chief Information Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2006
Savient Pharmaceuticals Obtains Temporary Restraining Order in Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Dec 2006
Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Nov 2006
Shire Sues Andrx Pharmaceuticals, L.L.C.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Nov 2006
Watson Completes Acquisition of Andrx
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2006
Joseph C. Papa Is New President and CEO at Perrigo Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2006
PhytoMedical Announces Appointment of Senior Pharmaceutical Executives to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2006
Watson and Unimed Pharmaceuticals, Inc. Settle Lawsuit Over AndroGel(R) Testosterone Gel
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 13 Sep 2006
Unimed Pharmaceuticals, Inc. Settles AndroGel(R) Litigation with Watson Pharmaceuticals, Inc. and Paddock Laboratories/Par Pharmaceutical Companies, Inc.
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 11 Sep 2006
Perrigo Announces Joseph C. Papa as New CEO; David T. Gibbons to Remain as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2006
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Sep 2006
Watson Names Thomas Russillo as President, U.S. Generics Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2006
Watson and Andrx Amend Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2006
Watson Pharmaceuticals Launches Pravastatin Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 4 Apr 2006
Andrx Announces Filing of NDA by Takeda for ACTOS and Extended-Release Metformin Combination Product
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 3 Apr 2006
Mr. Greg Wujek Appointed as President and CEO of PhytoMedical
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2006
Neuro-Hitech Pharmaceuticals, Inc. Signs Alzheimer's Transdermal Development Agreement with Xel
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Mar 2006
Watson to Acquire Andrx For $1.9 Billion, Creating the Third Largest Specialty Pharmaceutical Company In the U.S.
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 7 Mar 2006
Robert S. Mills Elected Chief Executive Officer of Columbia Laboratories
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Feb 2006
U.S. Food and Drug Administration Approves EMSAM(R) (selegiline transdermal system), the First Transdermal Patch for the Treatment of Major Depressive Disorder
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Feb 2006
Takeda Wins Patent Infringement Litigation Against ANDA Filers for Generic ACTOS(R) (pioglitazone HCl)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Jan 2006
Barr Names G. Frederick Wilkinson President and COO of Duramed Pharmaceuticals, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jan 2006
Columbia Laboratories Announces Management Changes
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 77

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 77 additional stories matching:
Watson Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.